1. Home
  2. Knowledge Base
  3. References
  4. Targeted delivery of immunotoxin by antibody to ganglioside GD3: A novel drug delivery route for tumor cells.

Targeted delivery of immunotoxin by antibody to ganglioside GD3: A novel drug delivery route for tumor cells.

Torres Demichelis V, Vilcaes AA, Iglesias-Bartolome R, Ruggiero FM, Daniotti JL (2013) Targeted delivery of immunotoxin by antibody to ganglioside GD3: A novel drug delivery route for tumor cells. PLoS One 8(1):e55304. doi: 10.1371/journal.pone.0055304

Summary: The authors used the mouse monoclonal antibody R24 against ganglioside G3 with Mab-ZAP (Cat. #IT-04) to test the viability of ganglioside G3 as a cancer therapy target. Varying concentrations of R24 were used on various cell lines with either 0.95 nM or 9.5 nM Mab-ZAP depending on the cell line.

Related Products: Mab-ZAP (Cat. #IT-04)

Read the featured article in Targeting Trends.